Literature DB >> 6344606

Association of hyponatremia with increased renin activity in chronic congestive heart failure: impact of diuretic therapy.

G L Schaer, A B Covit, J H Laragh, R J Cody.   

Abstract

A correlation between hyponatremia and increased plasma renin activity (PRA) has been reported in patients with severe congestive heart failure (CHF), implying both clinical and pathophysiologic significance. To determine the impact of diuretic therapy on this relation, we evaluated the correlation of serum sodium, prerenal azotemia (blood urea nitrogen/creatinine ratio [BUN/Cr] ), and PRA in 44 patients with severe CHF who were maintained on diuretic therapy. Serum sodium level was inversely related to PRA (r = -0.389, p less than 0.02). However, a significant correlation also existed between the BUN/Cr ratio and PRA (r = 0.365, p less than 0.025) and an inverse correlation between serum sodium level and the BUN/Cr ratio (r = 0.332, p less than 0.025). Multiple regression analysis of the 3 variables yielded significant interdependence (p less than 0.01). To evaluate the effect of diuretic therapy, 12 patients with severe CHF discontinued diuretic therapy and received, for 1 week each, 10 and 100 mEq sodium diets in balance studies. PRA ranged from 0.14 to 16 ng/ml/h. Despite this range, there was no significant correlation between either serum sodium or BUN/Cr ratio and PRA. It is concluded that the presence of marked hyponatremia and prerenal azotemia in patients with diuretic-treated CHF may suggest increased PRA. However, substantial patient-to-patient variability limits the predictive value of these correlations. Although some clinical value may be derived from such correlations, they should not be used to draw major inferences regarding the severity of CHF or the pathophysiology of water balance in CHF.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6344606     DOI: 10.1016/0002-9149(83)90200-x

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

1.  Hormonal, global, and regional haemodynamic responses to a vascular antagonist of vasopressin in patients with congestive heart failure with and without hyponatraemia.

Authors:  P Nicod; J Biollaz; B Waeber; J J Goy; R Polikar; J Schlapfer; M D Schaller; G A Turini; J Nussberger; K G Hofbauer
Journal:  Br Heart J       Date:  1986-11

Review 2.  Vasopressin receptor antagonists in patients with chronic heart failure.

Authors:  R De Vecchis; C Cantatrione; D Mazzei
Journal:  Herz       Date:  2016-09-15       Impact factor: 1.443

3.  Transient Hyponatremia During Hospitalization for Acute Heart Failure.

Authors:  Frederik H Verbrugge; Justin L Grodin; Wilfried Mullens; David O Taylor; Randall C Starling; W H Wilson Tang
Journal:  Am J Med       Date:  2016-02-01       Impact factor: 4.965

4.  Hyponatremia Predicts New-Onset Cardiovascular Events in Peritoneal Dialysis Patients.

Authors:  Hyung Woo Kim; Geun Woo Ryu; Cheol Ho Park; Ea Wha Kang; Jung Tak Park; Seung Hyeok Han; Tae-Hyun Yoo; Sug Kyun Shin; Shin-Wook Kang; Kyu Hun Choi; Dae Suk Han; Tae Ik Chang
Journal:  PLoS One       Date:  2015-06-08       Impact factor: 3.240

Review 5.  Vasopressin Receptor Antagonists for the Correction of Hyponatremia in Chronic Heart Failure: An Underutilized Therapeutic Option in Current Clinical Practice?

Authors:  Renato De Vecchis; Claudio Cantatrione; Damiana Mazzei; Cesare Baldi
Journal:  J Clin Med       Date:  2016-10-02       Impact factor: 4.241

6.  Prognostic impact of hyponatremia occurring at various time points during hospitalization on mortality in patients with acute myocardial infarction.

Authors:  Joon Seok Choi; Chang Seong Kim; Eun Hui Bae; Seong Kwon Ma; Young-Keun Ahn; Myung Ho Jeong; Soo Wan Kim
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.